• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Prophylactic anticoagulation associated with lower in-hospital and 60-day mortality for patients hospitalized with COVID-19

byYuchen DaiandMichael Pratte
June 18, 2021
in Emergency, Hematology, Infectious Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. For patients hospitalized with COVID-19, both prophylactic- and treatment-dose anticoagulation were associated with lower in-hospital mortality compared with no anticoagulation.

2. However, given that only prophylactic anticoagulation was associated with mortality benefit at 60 days, anticoagulation prophylaxis should be considered in all patients hospitalized with COVID-19.

Evidence Rating Level: 2 (Good)

Study Rundown: Venous thromboembolism (VTE) has been established as a leading complication of COVID-19 that has influenced clinical decision-making regarding VTE prophylaxis and treatment-dose anticoagulation in hospitalized patients. In recent months, there has been a collaborative emphasis on VTE prophylaxis for hospitalized COVID-19 patients with several experts advocating for increased doses of prophylactic anticoagulation in these high-risk patients. Furthermore, the potential benefits of these practices have been highlighted by recent clinical trials showing mortality benefit for both treatment- or prophylactic-dose anticoagulation as well as a significant decrease in the combined outcome of in-hospital mortality and organ support free days with treatment-dose anticoagulation in patients outside of intensive care. Given these findings, this retrospective cohort study sought to characterize the frequency and variation of VTE prophylaxis and treatment-dose anticoagulation use across hospitals over time in patients with COVID-19, as well as their effect on outcomes such as in-hospital and 60-day mortality. The main outcomes and measures of the analysis were the effects of nonadherence and variations in anticoagulation strategies on in-hospital and 60-day mortality assessed through multinomial logit models with inverse probability of treatment weighting. In total, from 1,351 hospitalized COVID-19 patients, 1,127 patients received anticoagulation. Additionally, both the use of prophylactic- and treatment-dose anticoagulation was associated with lower in-hospital mortality compared with no anticoagulation. However, only prophylactic-dose anticoagulation was associated with lower 60-day mortality. As with other retrospective studies looking at VTE, a limitation of this study was that investigators were limited by incomplete diagnostic workup for VTE across various acute clinical settings, exacerbated by hospital resources during the COVID-19 pandemic.

Click to read the study in JAMA Network Open

Click to read an accompanying editorial in JAMA Network Open

RELATED REPORTS

#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

#VisualAbstract: Reduced-Dose was Not Non-Inferior to Full-Dose Direct Oral Anticoagulants in Venous Thromboembolism Patients

Novel prophylactic anticoagulation scoring tool helps stratify patients following lower limb trauma

Relevant Reading: Anticoagulation, mortality, bleeding and pathology among patients hospitalized with COVID-19: a single health system study

In-Depth [retrospective cohort]: This large, multicenter cohort study of adults hospitalized with COVID-19 used a pseudorandom sample from 30 hospitals in the state of Michigan, United States. Data was compiled from patients hospitalized between March to June 2020 and analysis was completed through March 2021. In total, 1,351 hospitalized patients with COVID-19 were included in the analysis (median [IQR] age, 64 [52-75] years; 47.7% women, 48.9% Black patients). Of these, 1,127 patients received anticoagulation, 18 (1.3%) had a confirmed diagnosis of VTE, and 219 (16.2%) received treatment-dose anticoagulation. Across the 30 centers, use of treatment-dose anticoagulation without imaging ranged from 0% to 29% and gradually increased over time (adjusted odds ratio [aOR], 1.46; 95%CI, 1.31-1.61 per week). Of the 1,127 patients who did receive anticoagulation, 392 (34.8%) missed 2 or more days of prophylaxis. In addition, variation of nonadherence to prophylaxis ranged from 11% to 61% across centers and decreased markedly over time (aOR, 0.89; 95%CI, 0.82-0.97 per week). VTE nonadherence was associated with higher 60-day mortality (adjusted hazard ratio [aHR], 1.31; 95%CI, 1.03-1.67) excluding in-hospital mortality (aHR, 0.97; 95%CI, 0.91-1.03) and in particular, receiving any dose of anticoagulation was associated with lower overall in-hospital mortality (only prophylactic dose: aHR, 0.36; 95%CI, 0.26-0.52; any treatment dose: aHR, 0.38; 95%CI, 0.25-0.58). However, only prophylactic-dose anticoagulation was associated with lower 60-day mortality (prophylactic dose: aHR, 0.71; 95%CI, 0.51-0.90; treatment dose: aHR, 0.92; 95%CI, 0.63-1.35).

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: covid-19 infectionvenous thromboembolism (VTE)
Previous Post

Routine vaccination of children declined during the COVID-19 pandemic

Next Post

Discontinuation of statins in older patients with polypharmacy associated with increased cardiovascular events

RelatedReports

#VisualAbstract: Dapagliflozin Reduced Death and Worsening Heart Failure in Transcatheter Aor-tic-Valve Implantation
StudyGraphics

#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

April 22, 2025
#VisualAbstract: Reduced-Dose was Not Non-Inferior to Full-Dose Direct Oral Anticoagulants in Venous Thromboembolism Patients
StudyGraphics

#VisualAbstract: Reduced-Dose was Not Non-Inferior to Full-Dose Direct Oral Anticoagulants in Venous Thromboembolism Patients

March 10, 2025
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Chronic Disease

Novel prophylactic anticoagulation scoring tool helps stratify patients following lower limb trauma

April 11, 2024
Adolescent mothers in protective care more likely to have their children placed in care
Pediatrics

Children may have poorer mental health following a COVID-19 infection

July 7, 2023
Next Post
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial

Discontinuation of statins in older patients with polypharmacy associated with increased cardiovascular events

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

2 Minute Medicine Rewind June 21, 2021

The association between preoperative modified frailty index and postoperative complications in Chinese elderly patients with hip fractures

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.